News for 2004
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
CCOHTA Grants Program Provides Additional $1.6 Million to Develop Capacity for Health Technology Assessments
October 29, 2004
OTTAWA — The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) will make an additional $1.6 million available to further enhance the capacity of the Canadian health ...
Barbara Wells Appointed Director Of COMPUS
July 19, 2004
OTTAWA — CCOHTA’s Vice-President of CDR and COMPUS, Barb Shea, is pleased to announce the appointment of Barbara Wells as Director of COMPUS, effective July 19, 2004.The Canadian Optimal ...
New Hep C Treatment Reduces Viral Load, Increases Adverse Events
May 13, 2004
OTTAWA — The use of pegylated IFN combination (pegylated interferon alfa plus oral ribavirin) to treat chronic hepatitis C virus (HCV) infection reduces viral load but can increase the need ...
Breast Cancer Radiation Wait-Times Up to 12 Weeks: No Evidence of Impact on Local Recurrence
May 05, 2004
OTTAWA — A study published today by the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) found no relationship between the risk of local recurrence of breast cancer ...
CCOHTA announces VP, HTA
May 03, 2004
OTTAWA — CCOHTA President and CEO Dr. Jill M. Sanders is pleased to announce the appointment of Mike Gaucher as Vice President, Health Technology Assessment. As Vice President, Mr. Gaucher ...
CCOHTA Awards $1.6 Million In HTA Capacity Building Grants
March 30, 2004
OTTAWA—The Canadian Coordinating Office for Health Technology Assessment has awarded $1.6 million in grants to support innovative projects that will build the capacity to produce and use ...
CCOHTA to deliver Canadian Optimal Medication Prescribing and Utilization Service
March 11, 2004
OTTAWA — CCOHTA will deliver a new service approved by the Conference of Deputy Ministers of Health for promoting best practices in drug prescribing and use, CCOHTA President Dr. Jill M. ...
COX-2 Selective NSAIDs Not Always Easier on Your Stomach
March 10, 2004
OTTAWA — Not all COX-2 selective NSAIDs are safer than traditional NSAIDs concludes a recent systematic review by the Canadian Coordinating Office for Health Technology Assessment ...
Mike Gaucher Appointed Acting VP, HTA
February 26, 2004
OTTAWA — CCOHTA President Dr. Jill M. Sanders is pleased to announce the appointment of Mike Gaucher to the position of Acting Vice President, Health Technology Assessment.Initially ...
Bisphosphonates useful if other treatments fail
January 19, 2004
OTTAWA —Bisphosphonates are modestly effective in relieving the pain of cancer that has spread into bone concludes a recent systematic review by the Canadian Coordinating Office for Health ...
CCOHTA Launches HTA Capacity Building Grants Program
January 13, 2004
OTTAWA — CCOHTA has established a new grant program to enhance the capacity of the Canadian health care system to undertake, understand and apply health technology assessments and their ...